<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ferreira I</submitter><funding>Steno Diabetes Center Copenhagen (SDCC)</funding><funding>Per S. Henriksen Foundation</funding><funding>Aase and Ejnar Danielsen Foundation</funding><funding>Danish Diabetes Association</funding><funding>Poul and Erna Sehested Hansen Foundation</funding><pagination>231-241</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6448953</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>61(1)</volume><pubmed_abstract>&lt;h4>Aims/hypothesis&lt;/h4>Vascular inflammation and endothelial dysfunction are thought to contribute to arterial stiffening and hypertension. This study aims to test this hypothesis with longitudinal data in the context of type 1 diabetes.&lt;h4>Methods&lt;/h4>We investigated, in an inception cohort of 277 individuals with type 1 diabetes, the course, tracking and temporal inter-relationships of BP, specifically pulse pressure (a marker of arterial stiffening) and hypertension, and the following biomarkers of systemic and vascular inflammation/endothelial dysfunction: C-reactive protein (CRP), soluble intracellular adhesion molecule-1 (sICAM-1), soluble vascular cellular adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin). These biomarkers and other risk factors were measured at ba</pubmed_abstract><journal>Diabetologia</journal><pubmed_title>Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort.</pubmed_title><pmcid>PMC6448953</pmcid><funding_grant_id>SDCC 3.A Complications</funding_grant_id><pubmed_authors>Parving HH</pubmed_authors><pubmed_authors>Rossing P</pubmed_authors><pubmed_authors>Schalkwijk CG</pubmed_authors><pubmed_authors>Ferreira I</pubmed_authors><pubmed_authors>Hovind P</pubmed_authors><pubmed_authors>Stehouwer CDA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort.</name><description>&lt;h4>Aims/hypothesis&lt;/h4>Vascular inflammation and endothelial dysfunction are thought to contribute to arterial stiffening and hypertension. This study aims to test this hypothesis with longitudinal data in the context of type 1 diabetes.&lt;h4>Methods&lt;/h4>We investigated, in an inception cohort of 277 individuals with type 1 diabetes, the course, tracking and temporal inter-relationships of BP, specifically pulse pressure (a marker of arterial stiffening) and hypertension, and the following biomarkers of systemic and vascular inflammation/endothelial dysfunction: C-reactive protein (CRP), soluble intracellular adhesion molecule-1 (sICAM-1), soluble vascular cellular adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin). These biomarkers and other risk factors were measured at ba</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jan</publication><modification>2026-05-07T03:25:39.425Z</modification><creation>2026-04-07T22:34:16.348Z</creation></dates><accession>S-EPMC6448953</accession><cross_references><pubmed>29101422</pubmed><doi>10.1007/s00125-017-4470-5</doi></cross_references></HashMap>